Research News for 2011
-
Zometa Plus Hormonal Therapy Reduces Recurrence Risk
A study has found that Zometa and hormonal therapy after surgery could reduce the risk of the cancer coming back in premenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer better than hormonal therapy alone.
-
High C-Reactive Protein Levels May Influence Prognosis
Research suggests that C-reactive protein levels may be linked to prognosis after a breast cancer diagnosis.
-
FDA Says Thermography Shouldn’t Be Substituted for Mammograms
The FDA has warned that thermography should not be substituted for mammography.
-
Lipofilling Doesn’t Increase Recurrence Risk
Research suggests that women who had lipofilling after breast cancer surgery and reconstruction are no more likely to have the cancer come back than women who never had lipofilling.
-
Long-Term Smoking Increases Risk in High-Risk Women
A very large research study strongly suggests that smoking for a long time dramatically increases breast cancer risk in women with a higher-than-average risk of breast cancer.
-
Can Coffee Reduce Risk?
New research suggests that drinking five or more cups of coffee per day may reduce the risk of postmenopausal breast cancer, particularly hormone-receptor-negative breast cancer.
-
Experimental Genomic Test May Help Determine Need for Chemo Before Surgery
An experimental genomic test may help doctors figure out if invasive HER2-negative breast cancer will respond to chemotherapy before surgery.
-
Survey: Women Happy with Prophylactic Mastectomy Choice 20 Years Later
Two surveys show that about 90% of women who decide to have contralateral prophylactic mastectomy are satisfied with their decision and would make the same decision again.
-
Research Supports Value of Screening Mammograms Starting at 40
Two new studies underscore the value of annual screening mammograms starting at age 40.
-
Radiation After Lumpectomy to Remove DCIS Lowers Recurrence Risk
Research shows that women diagnosed with DCIS who were treated with radiation therapy after surgery have a lower risk of the cancer coming back than women treated only with surgery.
